Time-Restricted Fasting Improves Liver Steatosis in Non-Alcoholic Fatty Liver Disease—A Single Blinded Crossover Trial
Open accessThe DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is associated with visceral adiposity. We assessed the effectiveness of time-restricted fasting (TRF) for 16 h daily without calorie restrictions compared to standard care (SC; diet and lifestyle advice) in improving visceral adiposity and steatosis via controlled attenuation parameter (CAP). Methods: In a prospective single-blind randomized controlled trial, 32 participants with NAFLD were randomly assigned to TRF or SC for 12 weeks. The secondary endpoints were changes in liver stiffness, anthropometry, blood pressure, and other metabolic factors. Results: Twenty-eight participants completed the first arm of the study (TRF = 14, SC = 14), with 23 completing the crossover arm (TRF = 10, SC = 13). The baseline demographics were similar between the groups. Intermittent fasting caused a significant decrease in hepatic steatosis (p = 0.038), weight (p = 0.005), waist circumference (p = 0.001), and BMI (p = 0.005) compared to standard care. Intermittent fasting also resulted in additional within-group changes that were not seen in the standard care intervention. Conclusion: TRF offers superior improvements in patients with NAFLD, improving steatosis, weight, and waist circumference despite a lack of change in overall caloric intake. Time-restricted fasting should be considered as a primary weight loss intervention in the context of NAFLD. Trial registration: ACTRN12613000935730.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seven trials found no significant between-group differences in energy intake during the intervention (21, 24, 25), in change from baseline (16, 18, 25), or in post-intervention energy intake (20, 22), whereas two studies reported lower caloric intake in the IF groups than in the CER groups (23, 24).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Eight trials employed a parallel-group design (16, 18–24), and one utilized a crossover design (25).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Flint, A., Raben, A., Blundell, J., & Astrup, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801083 · Cited by 2,238
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,196
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Karlas, T., Petroff, D., Sasso, M., Fan, J.-G., Mi, Y.-Q., de Lédinghen, V., Kumar, M., Lupsor-Platon, M., Han, K.-H., Cardoso, A. C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.022 · Cited by 1,275 · cited 1×
“A subgroup of those with CAP values > 268 dB/m ( n = 10 [TRF], 10 [SC]), the cut-off considered for significant steatosis [18,19], demonstrated even larger decreases in CAP values after the TRF intervention, with a mean decrease of 26.10 ( ± 33.01) dB/m compared to an increase of 15.10 ( ± 17.49)…”
BackgroundInfluentialNon-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Yki-Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,259
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942
Self-citationAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 852
Abdominal Fat: Standardized Technique for Measurement at CT
Yoshizumi, T., Nakamura, T., Yamane, M., Waliul Islam, A. H. M., Menju, M., Yamasaki, K., Arai, T., Kotani, K., Funahashi, T., Yamashita, S., et al. (1999) · Radiology · doi:10.1148/radiology.211.1.r99ap15283 · Cited by 829
Schwenzer, N. F., Springer, F., Schraml, C., Stefan, N., Machann, J., & Schick, F. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.023 · Cited by 749
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.002 · Cited by 711
Younossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease†
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 607
Self-citationCalorie restriction with or without time-restricted eating in weight loss
Liu, D., Huang, Y., Huang, C., Yang, S., Wei, X., Zhang, P., Guo, D., Lin, J., Xu, B., Li, C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2114833 · Cited by 516
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Liver Fat in the Metabolic Syndrome
Kotronen, A., Westerbacka, J., Bergholm, R., Pietiläinen, K. H., & Yki-Järvinen, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0482 · Cited by 457
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
INTERSALT study findings. Public health and medical care implications
Stamler, J., Rose, G., Stamler, R., Elliott, P., Dyer, A., & Marmot, M. (1989) · Hypertension · doi:10.1161/01.hyp.14.5.570 · Cited by 426 · cited 1×
“There was a > 4 mmHg reduction with the TRF intervention, a clinically relevant improvement, as a 3 mmHg reduction in SBP equates to an 8% reduction in stroke mortality and a 5% reduction in mortality due to coronary heart disease [34].”
Hepatic steatosis: Innocent bystander or guilty party?
Day, C. P., & James, O. F. W. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 388
de Lédinghen, V., Vergniol, J., Foucher, J., Merrouche, W., & le Bail, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02820.x · Cited by 367
Alternate-day fasting and chronic disease prevention: a review of human and animal trials
Varady, K. A., & Hellerstein, M. K. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.7 · Cited by 358
Myers, R. P., Pollett, A., Kirsch, R., Pomier‐Layrargues, G., Beaton, M., Levstik, M., Duarte‐Rojo, A., Wong, D., Crotty, P., & Elkashab, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02781.x · Cited by 343
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
Drenick, E. J., Simmons, F., & Murphy, J. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197004092821502 · Cited by 291
Jamshed, H., Steger, F. L., Bryan, D. R., Richman, J. S., Warriner, A. H., Hanick, C. J., Martin, C. K., Salvy, S.-J., & Peterson, C. M. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.3050 · Cited by 280
The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Zavos, C., & Tsiaousi, E. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01176.x · Cited by 277
ENERGY INTAKE, MEAL FREQUENCY, AND HEALTH: A Neurobiological Perspective
Mattson, M. P. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092526 · Cited by 258
Leptin in nonalcoholic fatty liver disease: A narrative review
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.012 · Cited by 235 · cited 1×
“Leptin is thought to have pro-inflammatory and pro-fibrotic effects in NAFLD [31].”
BackgroundKoopman, K. E., Caan, M. W. A., Nederveen, A. J., Pels, A., Ackermans, M. T., Fliers, E., la Fleur, S. E., & Serlie, M. J. (2014) · Hepatology · doi:10.1002/hep.27149 · Cited by 154
Weight Loss and Blood Pressure Control (Pro)
Harsha, D. W., & Bray, G. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.094011 · Cited by 134
Del Corral, P., Chandler-Laney, P. C., Casazza, K., Gower, B. A., & Hunter, G. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1057 · Cited by 125
Plasma adiponectin levels and risk of myocardial infarction in men
Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B., & Rimm, E. B. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.06.063 · Cited by 113
Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis
Li, T., Yu, T., Hawkins, B. S., & Dickersin, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133023 · Cited by 107 · cited 1×
“A paired analysis (paired t test or Wilcoxon signed rank test) of within-individual change was used to identify the differences between the interventions, with each individual acting as their own internal control for the analysis [17].”
MethodRelationship Between Weight Loss Maintenance and Changes in Serum Leptin Levels
Wing, R., Sinha, M., Considine, R., Lang, W., & Caro, J. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979881 · Cited by 102
The liver and the waistline: Fifty years of growth
Farrell, G. C. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06080.x · Cited by 54
Fatty Liver Characterization and Classification by Ultrasound
Ribeiro, R., & Sanches, J. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-02172-5_46 · Cited by 40
Gosal, H., Kaur, H., Ngassa, H. C., Elmenawi, K. A., Anil, V., & Mohammed, L. (2021) · Cureus · doi:10.7759/cureus.15618 · Cited by 19
Cited by
Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70132 · Cited by 153
Panganiban, J. A., Kehar, M., Ibrahim, S. H., Hartmann, P., Sood, S., Hassan, S. M., Ramirez, C. M., Kohli, R., Censani, M., Mauney, E. E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100164 · Cited by 73
Tsitsou, S., Bali, T., Adamantou, M., Saridaki, A., Poulia, K., Karagiannakis, D. S., Papakonstantinou, E., & Cholongitas, Ε. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70044 · Cited by 44
Chrononutrition in the Prevention and Management of Metabolic Disorders: A Literature Review
Mentzelou, M., Papadopoulou, S. Κ., Psara, E., Voulgaridou, G., Pavlidou, E., Androutsos, O., & Giaginis, C. (2024) · Nutrients · doi:10.3390/nu16050722 · Cited by 48
The Catabolic—Anabolic Cycling Hormesis Model of Health and Resilience
Calabrese, E. J., & Mattson, M. P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102588 · Cited by 38
Metadata
- Authors
- Feehan, J., Mack, A., Tuck, C., Tchongue, J., Holt, D. Q., Sievert, W., Moore, G. T., de Courten, B., & Hodge, A.
- Affiliations
- Victoria University (AU)
- Monash University (AU)
- Monash Health (AU)
- School of Health and Biomedical Sciences, RMIT, Bundoora 3083, Australia
- Corresponding author
- Hodge, Alexander
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-11-22
- Volume
- 15
- Issue
- 23
- Pages
- 4870
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10708421
- OpenAlex
- W4388906506
- Cited by
- 47
- References
- 41
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 5
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- Monash University
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, visceral fat, controlled attenuation parameter, liver stiffness, weight loss, waist circumference, intermittent fasting
- MeSH terms
- Intermittent Fasting, Humans, Liver, Prospective Studies, Single-Blind Method, Cross-Over Studies, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
